Two men on the same weekly dose of testosterone can end up with completely different blood levels, different hematocrit, and different side effects. The variable is the route, not the dose.
Most men researching testosterone replacement spend their time on the dose and almost none on the route. That is backwards. The delivery method decides how far blood levels swing between doses, how quickly the treatment can be stopped if something goes wrong, whether hematocrit becomes a recurring problem, how much of the cost falls on the patient, and whether a partner or child in the house is exposed to the drug. Here is how the five available routes actually differ, and what each one costs in convenience, stability, and reversibility.
Testosterone replacement therapy is not one treatment. It is a single molecule delivered through five different routes, and the route changes the experience of treatment more than the milligram number on the prescription does. A man on 100 mg of testosterone cypionate injected once a week and a man using a daily transdermal gel may end up with similar average testosterone levels across a month, yet one of them is riding a peak and trough cycle every seven days while the other sits close to flat. Those two men will report different moods, different energy patterns, and often different side effects.
The five routes currently available to men in the United States are intramuscular or subcutaneous injection, transdermal gel or cream, subcutaneous pellets, oral testosterone undecanoate capsules, and nasal gel. Each has a distinct pharmacokinetic signature, a distinct monitoring burden, and a distinct failure mode. This article compares them on the variables that actually determine whether a man stays on treatment: blood level stability, effect on hematocrit, fertility impact, reversibility, transference risk, and out of pocket cost.
8 days
Approximate elimination half-life of testosterone cypionate, the most commonly prescribed injectable ester in the United States
Testosterone enanthate sits closer to 4.5 days, which is why enanthate users often split doses more frequently than cypionate users.
~10%
Typical fraction of an applied transdermal gel dose that is actually absorbed through the skin
This is why a 50 to 100 mg daily gel dose and a 100 mg weekly injection can produce comparable serum levels.
3 to 6 mo
Duration of action of subcutaneous testosterone pellets after a single in-office insertion
The convenience and the core problem are the same fact. Once the pellets are in, the dose cannot be adjusted without a surgical removal.
2x daily
Dosing frequency required for oral testosterone undecanoate capsules, taken with a fat-containing meal
Absorption runs through the intestinal lymphatic system rather than the portal vein, which is why these capsules avoid the liver toxicity of older oral androgens.
5,246
Number of men enrolled in the TRAVERSE trial, which tested transdermal testosterone gel against placebo for cardiovascular safety
Lincoff and colleagues, New England Journal of Medicine, 2023. Testosterone gel was non-inferior to placebo for major adverse cardiac events in men with hypogonadism and cardiovascular risk.
3x daily
Dosing schedule for nasal testosterone gel, the one route studied specifically for preserving the pituitary signals that drive sperm production
Short pulsatile exposure appears to suppress luteinizing hormone less than continuous routes, which matters for men who still want children.
Which testosterone delivery method is right for most men?
For most men starting testosterone replacement, a small-volume subcutaneous injection taken twice a week is the default that balances cost, blood level stability, and reversibility better than the alternatives. Generic testosterone cypionate is inexpensive, the dose can be changed the same week a lab result comes back, and splitting the weekly total into two smaller shots flattens the peak and trough pattern that causes the classic complaint of feeling strong on day two and flat on day seven. Subcutaneous administration with an insulin syringe also removes the intimidation factor of a deep intramuscular injection, which is a real adherence variable rather than a cosmetic one.
That default has exceptions worth naming. A man with a genuine needle phobia will do better on a gel than on the theoretically superior injection he stops taking after three weeks. A man who travels constantly and cannot manage refrigeration or a sharps container may be the rare case where pellets earn their cost. A man who is actively trying to conceive should not be on conventional testosterone replacement at all without a fertility-preserving strategy in place. The best route is the one a specific man will actually use, monitored properly, for years.
Testosterone Delivery Routes Compared on the Variables That Matter
| Route | Typical Schedule | Blood Level Pattern | Main Advantage | Main Drawback |
|---|---|---|---|---|
| Intramuscular injection, cypionate or enanthate | Every 7 to 14 days, 100 to 200 mg | Sharp peak at day 2 to 3, trough by day 7 or later | Cheapest route available and well understood by every prescriber | Widest swing between peak and trough, and the largest hematocrit rise of any route at equivalent doses |
| Subcutaneous injection, cypionate or enanthate | Twice weekly, 40 to 80 mg per shot | Noticeably flatter than weekly intramuscular dosing | Small insulin syringe, less injection anxiety, smoother levels, same low drug cost | Two injections per week instead of one, and occasional injection site lumps in lean men |
| Weekly subcutaneous auto-injector | Once weekly, 50 to 100 mg | Steadier than intramuscular at the same interval | No vial, no syringe drawing, and a fixed dose that removes measurement error | Carries a boxed warning for blood pressure increase, and costs far more than a generic vial |
| Transdermal gel or compounded cream | Daily, usually morning application | The flattest profile of any route, close to a natural daily rhythm | No needles, near-physiologic stability, and immediate reversibility on stopping | Transference to partners and children is a genuine boxed-warning risk, and roughly one man in five absorbs poorly |
| Subcutaneous pellets | In-office insertion every 3 to 6 months | High for the first weeks, declining slowly over months | Nothing to remember between visits, which suits men who forget doses | Dose cannot be adjusted after insertion, and extrusion, bleeding, or site infection occur in a meaningful minority |
| Oral testosterone undecanoate capsules | Twice daily with a fat-containing meal | Two peaks per day, with meaningful variability between men | No needles, no transference risk, and no liver toxicity of the older oral androgens | Highest cash cost of any route, food-dependent absorption, and a boxed warning for blood pressure increase |
| Nasal gel | Three times daily, one pump per nostril | Short pulses that clear quickly between doses | The route with the best evidence for preserving luteinizing hormone and sperm production | Three doses every day is a demanding schedule, and nasal irritation is a common reason men stop |
How much do blood levels actually swing between injection schedules?
The swing between peak and trough is the single largest practical difference between injection schedules, and it is driven by dosing interval rather than by total weekly dose. A 200 mg intramuscular injection given every two weeks, still a common prescription pattern, pushes serum testosterone well above the upper limit of the reference range in the first days and lets it fall below the starting point before the next dose is due. Men on that schedule frequently describe a good first week and a bad second week, and the fix is almost never a higher dose. It is a shorter interval with a proportionally smaller amount per injection.
Splitting the same weekly total into two subcutaneous injections cuts the amplitude of that cycle substantially without changing the milligrams delivered per week. Some men go further and inject small daily amounts, which approaches the flatness of a transdermal gel while keeping the cost advantage of a generic vial. The trade is administrative rather than clinical: more injections means more supplies, more sharps disposal, and more opportunities to skip a dose while traveling.
These curves are a teaching device rather than measured trial data, and the point they carry is narrow. Average testosterone across the week can be nearly identical for all three schedules while the day to day experience differs enormously. This is also why a single blood draw is close to meaningless without knowing when the last dose was given. A trough level drawn on day seven of a weekly injection and a level drawn 48 hours after that same injection are two different numbers from the same man on the same protocol.
Why does hematocrit rise more on injections than on gels?
Erythrocytosis, meaning an elevated red blood cell concentration, is the most common laboratory abnormality on testosterone replacement, and it tracks with peak concentration rather than with average level. Injectable routes that produce a supraphysiologic spike in the days after each dose stimulate erythropoiesis more strongly than transdermal routes that hold levels flat, even when both routes deliver the same weekly milligrams. This is the clearest example of the route mattering independently of the dose.
Practically, this means a man whose hematocrit keeps climbing past the threshold his physician is comfortable with has options beyond simply reducing his dose. Shortening the injection interval to lower the peak, or switching to a transdermal route entirely, both address the mechanism directly. Hydration status, sleep apnea, and smoking all contribute independently and are frequently the real driver in a man whose numbers look worse than his dose would predict.
What is the real catch with testosterone pellets?
The defining problem with subcutaneous testosterone pellets is that the dose is irreversible for the life of the implant. Pellets are inserted through a small incision in the upper buttock or hip under local anesthetic, typically as six to twelve 75 mg pellets, and they release testosterone slowly over three to six months. If the resulting level is too high, or hematocrit climbs, or the man simply does not tolerate treatment, the only ways forward are waiting several months or a surgical removal that is not always straightforward.
The secondary issues are mechanical. A percentage of pellets extrude back out through the insertion site, particularly in the first two weeks and particularly in lean or very active men. Site bleeding, bruising, and infection all occur at rates higher than any other route because pellets are the only route that involves a minor surgical procedure. Pellets also tend to produce elevated levels in the first weeks and declining levels toward the end of the cycle, so men on this route often report a rhythm across months rather than across days.
Transference Is Not a Theoretical Risk
Transdermal testosterone gels carry a boxed warning for secondary exposure because measurable virilization has been reported in children and female partners after skin to skin contact with an application site. The mitigations are specific: apply to shoulders, upper arms, or abdomen depending on the product's labeling, let the site dry fully, wash hands immediately, and cover the area with clothing. Households with young children should weigh this route carefully against injectable alternatives that carry no transference risk at all.
Do oral testosterone capsules actually work?
Modern oral testosterone undecanoate capsules do raise serum testosterone into the target range for most men, and they do so without the liver toxicity that made older oral androgens like methyltestosterone unacceptable. The mechanism behind that difference is absorption route. Testosterone undecanoate in an oil-based formulation is taken up by the intestinal lymphatic system and enters circulation while bypassing first-pass metabolism in the liver, which is exactly what the older 17-alpha-alkylated oral androgens could not do.
The practical limitations are real and worth stating plainly. These capsules must be taken twice daily with a meal containing fat, because absorption depends on it, and a man who takes his morning dose with black coffee is under-dosing himself without knowing it. Blood pressure increases have been observed consistently enough across this drug class to earn a boxed warning, which makes home blood pressure monitoring a requirement rather than a suggestion. Cash cost is also the highest of any route by a wide margin, and insurance coverage is frequently denied when a generic injectable exists.
This distribution is approximate and drawn from the general pattern of US prescribing rather than from a single audited dataset. The shape is the useful part. Injectables dominate because they are inexpensive and because insurance plans steer toward them, not because they are pharmacokinetically superior to a daily gel. Cost, not physiology, is the main reason most American men on testosterone replacement are holding a syringe.
Which route is best if you still want children?
Every conventional route of testosterone replacement suppresses the pituitary signals that drive sperm production, and nasal gel is the only route with meaningful evidence of doing so less. Exogenous testosterone suppresses luteinizing hormone and follicle stimulating hormone through negative feedback on the hypothalamus and pituitary, which shuts down the intratesticular testosterone concentration that spermatogenesis requires. That suppression is why a man on testosterone replacement can have a normal serum testosterone level and a sperm count near zero at the same time.
Nasal testosterone gel produces short pulses that clear between doses rather than a continuous elevation, and trials of this route have reported preservation of luteinizing hormone and sperm parameters in a way that injections and gels do not match. For men who want to preserve fertility, the other established options are adding human chorionic gonadotropin alongside testosterone to maintain testicular stimulation, or skipping testosterone entirely in favor of a selective estrogen receptor modulator such as enclomiphene that raises the body's own production upstream. This decision belongs in a conversation with a physician before starting treatment rather than after, because recovery of sperm production after prolonged suppression can take many months.
1
Confirm the Diagnosis
Two morning total testosterone draws on separate days, plus LH, FSH, prolactin, and a symptom assessment
2
Settle Fertility First
If children are still wanted, that constraint eliminates most routes before cost or convenience is discussed
3
Screen the Household
Young children or a pregnant partner at home moves transdermal gel down the list on transference grounds
4
Match Route to Adherence
The best route is the one this specific man will use weekly for years, not the one with the prettiest curve
5
Reassess at Week 8
Trough level, hematocrit, estradiol, and symptom response decide whether the route or the interval changes
What does monitoring look like on any route?
Monitoring on testosterone replacement follows roughly the same schedule regardless of delivery route, with one route-specific detail attached to the timing of the blood draw. Baseline labs before starting should include two separate morning total testosterone measurements, free testosterone or sex hormone binding globulin, luteinizing hormone and follicle stimulating hormone, estradiol, a complete blood count for baseline hematocrit, a lipid panel, and a prostate specific antigen measurement in men over 40. Blood pressure should be documented at baseline for every man and monitored at home on the oral and auto-injector routes.
Standard Monitoring Schedule and the Route-Specific Detail That Changes
| Timepoint | What to Measure | Route-Specific Consideration |
|---|---|---|
| Baseline, before first dose | Two morning total testosterone draws, free T or SHBG, LH, FSH, estradiol, CBC, lipids, PSA if over 40, blood pressure | Semen analysis is worth adding for any man who has not completed his family, on any route |
| Week 6 to 8 | Total testosterone, hematocrit, estradiol, symptom review, blood pressure | Draw at trough for injections, 2 to 8 hours after application for gels, and mid-cycle for pellets |
| Month 6 | Total testosterone, hematocrit, estradiol, PSA if indicated, blood pressure | Pellet users should time this near the end of a cycle to see how far levels have fallen |
| Month 12 and annually | Full panel including lipids and PSA, plus a review of whether the route is still the right one | Rising hematocrit is a reason to reconsider interval and route, not only dose |
| Any time symptoms change | Total testosterone timed to the dosing schedule, hematocrit, blood pressure | A level drawn without noting time since last dose cannot be interpreted on any injectable route |
Month 0: Diagnosis and route selection
Weeks 1 to 6: Establish the routine
Weeks 6 to 8: First reassessment
Months 3 to 6: Refinement
Months 6 to 12: Steady state
How much does each route cost out of pocket?
Cost separates the routes more sharply than clinical performance does. Generic testosterone cypionate is one of the least expensive prescription drugs a man is likely to be given, often falling under 50 dollars a month in cash price including syringes and needles. Generic transdermal gel has come down considerably but still costs several times that. Branded gels, weekly auto-injectors, pellet insertion procedures, and oral capsules all sit an order of magnitude higher, and pellet costs are usually quoted per procedure rather than per month, which obscures the comparison.
Cost is also the reason a great many men end up on a route nobody would have chosen for them on physiological grounds. Insurance plans that cover generic injectable testosterone and deny everything else effectively make the route decision before the physician does. Knowing that the denial is a formulary decision rather than a clinical judgment is useful, because a documented failure or intolerance of the preferred route is frequently what opens access to an alternative.
When is switching routes the right move?
Switching delivery routes is warranted when the problem is clearly a property of the route rather than of the dose. Peak and trough mood swings on a long injection interval, hematocrit that keeps climbing despite a reasonable weekly dose, poor absorption on a gel confirmed by a low level drawn at the right time, and a household situation that makes transference unacceptable are all route problems with route solutions. Raising or lowering milligrams does not fix any of them.
The reverse is also worth saying. Fatigue that has not improved after three months at a confirmed mid-range testosterone level is usually not a route problem and often not a testosterone problem at all. Untreated sleep apnea, iron deficiency, thyroid dysfunction, depression, and simple under-recovery from training all produce the symptom set men attribute to inadequate replacement. Changing routes in that situation adds cost and disruption without addressing the cause.
Medical Disclaimer
This article is for educational purposes only and is not medical advice. Nothing here diagnoses, treats, cures, or prevents any disease, including hypogonadism or infertility. Testosterone in all forms is a controlled prescription medication and decisions to start, switch, adjust, or stop it must be made with a licensed physician who knows your full medical history. Human chorionic gonadotropin and enclomiphene are prescription medications and are not appropriate for self-directed use. The charts and cost figures shown here are illustrative demonstrations of direction and magnitude rather than measured trial results or price quotes, and the studies referenced differ in population, dose, formulation, and duration so their figures are not directly comparable. Product availability, labeling, boxed warnings, and formulary coverage vary by country and change over time. Speak with a licensed healthcare professional about your bloodwork and medical history before making any decision.
Continue Reading